SEC Enforcement: Court Fines Advisor for Misleading Clients Into Switching Firms
Meanwhile, SEC charges four with posing as portfolio managers to steal inside information and then trading on it.
Pharma Patent Ruling Pinches Opportunities in Emerging Markets
The decision by an Indian court not to grant a new patent to Novartis for a modified form of its cancer drug Glivec was a heavy blow to the company.
Philanthropy Focus: Page Snow on Advisors and 'Impact' Investing
If you want wealthy clients, learn about a new trend of mission-related investments. Page Eberstadt Snow, Foundation Source's chief philanthropic officer, says private foundations are judging advisors by their expertise in this area.